Latest news with #MatthewGillmor
Globe and Mail
3 days ago
- Business
- Globe and Mail
UnitedHealth (UNH) Gets a Buy from KeyBanc
In a report released today, Matthew Gillmor CFA from KeyBanc maintained a Buy rating on UnitedHealth (UNH – Research Report), with a price target of $400.00. Confident Investing Starts Here: According to TipRanks, Gillmor CFA is an analyst with an average return of -6.7% and a 37.93% success rate. Gillmor CFA covers the Healthcare sector, focusing on stocks such as UnitedHealth, Acadia Healthcare, and Encompass Health. In addition to KeyBanc, UnitedHealth also received a Buy from Bernstein's Lance Wilkes in a report issued on May 21. However, on the same day, HSBC downgraded UnitedHealth (NYSE: UNH) to a Sell. See Insiders' Hot Stocks on TipRanks >> The company has a one-year high of $630.73 and a one-year low of $248.88. Currently, UnitedHealth has an average volume of 14.35M. Based on the recent corporate insider activity of 147 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of UNH in relation to earlier this year. Last month, Timothy Patrick Flynn, a Director at UNH bought 1,533.00 shares for a total of $491,786.40.
Business Insider
3 days ago
- Business
- Business Insider
‘Time to Load Up,' Says KeyBanc About UnitedHealth Stock
UnitedHealth (NYSE:UNH) has had a very disappointing run so far this year, with shares of the healthcare giant down roughly 40% year-to-date, pushing its P/E valuation to levels not seen in over a decade. Confident Investing Starts Here: What began as a year of high hopes – buoyed by expectations of a favorable Medicare Advantage underwriting cycle under the new administration and UnitedHealth's strength relative to competitors – has unraveled rapidly. It started with underwhelming Q1 results, followed by a surprising CEO transition, suspended guidance, and signs of deeper challenges beneath the surface. These included rising costs for Medicare Advantage members at UHC, and under-coding issues tied to new Optum enrollees in 2024. Adding further pressure, the Wall Street Journal reported that the Department of Justice is investigating the company for potential Medicare fraud. But savvy investors take note. Beaten-down stocks often represent a big opportunity – that is after all what the maxim 'buy low, sell high' is all about. And it's definitely time to load up, says KeyBanc's Matthew Gillmor. 'In our view,' said the analyst, 'the stock has likely overshot to the downside.' Gillmore explains why. Historically, UNH has traded at a forward P/E multiple of 17–19x, but it now trades closer to 12x. Assuming a more normalized long-term multiple of 14x, this suggests an EPS power of roughly $21.50 – about $8.25 per share below the company's original 2025 guide. On a pre-tax basis, this equates to a $9.5 billion shortfall. In analyzing this gap, Gillmor thinks the market is assigning significant weight to pressures from Optum's coding headwinds and margin compression in the MA segment. 'We figure this implied EPS power potentially embeds ~0% margins for MA,' Gillmor explained. 'We think this is a very conservative posture that is unlikely to sustain over the long term.' Additionally, Gillmor thinks the challenges the company faces this year should be fixed in 2026. According to the analyst, the necessary corrective actions are already well understood: propose more conservative MA bids in June and make use of the HouseCalls program to improve coding accuracy for new members. Even partial success in implementing these measures could result in a meaningful earnings boost next year. For instance, recovering just $1.5 billion in Optum revenue – roughly half of the estimated opportunity – and improving MA margins by just 1% could add approximately $2.50 to EPS, representing an 11% uplift relative to 2025 consensus estimates. For jittery investors, Gillmor advises to hold steady as the current share price is too good to ignore. 'While patience will be required and uncertainty is elevated, we think the 12- month+ setup from here is attractive: UNH is the bellwether MCO, trading at a historically discounted valuation on depressed margins,' the analyst summed up. Bottom line, Gillmor assigns an Outperform (i.e., Buy) rating for UNH shares and although his price target goes from $450 to $400, the revised figure still offers a one-year upside of 31%. (To watch Gillmor's track record, click here) Turning now to the broader Street view, where UNH stock claims a Moderate Buy consensus rating based on a mix of 19 Buys, 6 Holds and 1 Sell. Going by the $378.32 average price target, a year from now, shares will be changing hands for a 24% premium. (See UNH stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.
Yahoo
23-04-2025
- Business
- Yahoo
Is Acadia Healthcare Company Inc (ACHC) The Top Falling Stock with Unusual Volume?
We recently published a list of . In this article, we are going to take a look at where Acadia Healthcare Company Inc (NASDAQ:ACHC) stands against other top falling stocks with unusual volume. Uncertainty around tariffs and macroeconomic conditions has dented investor confidence, resulting in stock prices falling. While some stocks have come under pressure due to the above two reasons, others have simply followed the market direction or have dipped for company-specific reasons. Regardless of the reasons for stocks going down, falling stocks provide an opportunity for fresh investors to get in at good prices. Once the risks subside, these stocks usually recover quickly as well. We decided to uncover these stocks and see if it makes sense to put money in them to take advantage of the ongoing market turmoil. To come up with our list of top 20 stocks falling with unusual volume, we looked at stocks over $300 million in market cap, their one-week performance, and used relative volume to detect the unusual volume activity. Relative volume compares the daily volume to the three-month average trading volume of the stock, making it easy to detect spikes in volume. These spikes usually signal something important is happening, which, when combined with falling prices, becomes a red flag that investors can't ignore. A healthcare professional discussing a treatment plan with a patient in an outpatient clinic. Acadia Healthcare Company Inc (NASDAQ:ACHC) is a behavioral healthcare services provider. It operates and develops comprehensive treatment centers, acute inpatient psychiatric facilities, residential treatment centers, and specialty treatment facilities comprising residential recovery facilities and eating disorder facilities. The firm's stock is down 11.71% in a week on a relative volume of 3.17. The company earned an upgrade at the start of this year. KeyBanc Capital Markets analyst Matthew Gillmor upgraded the firm from Sector Weight to Overweight on the back of an expected potential momentum of its EBITDA in 2026. He assigned a price target of $70 to Acadia Healthcare Company Inc (NASDAQ:ACHC). Analyst Matthew Gillmor stated: 'We think valuation can begin to normalize during 2025 (to >9x), as negative press headlines from 2024 fade and 2026 EBITDA comes into focus.' A similar sentiment was shown by another analyst only a few days ago. Guggenheim analyst Jason Cassorla upgraded the stock to Buy with a price target of $36. He was optimistic about the long-term outlook of the industry. The company's valuation seems attractive regardless of the current market conditions. However, there is no meaningful short-term catalyst for the business itself, so the direction of the broader market may well determine investor returns in this case. Overall, ACHC ranks 8th on our list of top falling stocks with unusual volume. While we acknowledge the potential of ACHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ACHC but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at . Sign in to access your portfolio
Yahoo
22-04-2025
- Business
- Yahoo
Is Acadia Healthcare Company Inc (ACHC) The Top Falling Stock with Unusual Volume?
We recently published a list of . In this article, we are going to take a look at where Acadia Healthcare Company Inc (NASDAQ:ACHC) stands against other top falling stocks with unusual volume. Uncertainty around tariffs and macroeconomic conditions has dented investor confidence, resulting in stock prices falling. While some stocks have come under pressure due to the above two reasons, others have simply followed the market direction or have dipped for company-specific reasons. Regardless of the reasons for stocks going down, falling stocks provide an opportunity for fresh investors to get in at good prices. Once the risks subside, these stocks usually recover quickly as well. We decided to uncover these stocks and see if it makes sense to put money in them to take advantage of the ongoing market turmoil. To come up with our list of top 20 stocks falling with unusual volume, we looked at stocks over $300 million in market cap, their one-week performance, and used relative volume to detect the unusual volume activity. Relative volume compares the daily volume to the three-month average trading volume of the stock, making it easy to detect spikes in volume. These spikes usually signal something important is happening, which, when combined with falling prices, becomes a red flag that investors can't ignore. A healthcare professional discussing a treatment plan with a patient in an outpatient clinic. Acadia Healthcare Company Inc (NASDAQ:ACHC) is a behavioral healthcare services provider. It operates and develops comprehensive treatment centers, acute inpatient psychiatric facilities, residential treatment centers, and specialty treatment facilities comprising residential recovery facilities and eating disorder facilities. The firm's stock is down 11.71% in a week on a relative volume of 3.17. The company earned an upgrade at the start of this year. KeyBanc Capital Markets analyst Matthew Gillmor upgraded the firm from Sector Weight to Overweight on the back of an expected potential momentum of its EBITDA in 2026. He assigned a price target of $70 to Acadia Healthcare Company Inc (NASDAQ:ACHC). Analyst Matthew Gillmor stated: 'We think valuation can begin to normalize during 2025 (to >9x), as negative press headlines from 2024 fade and 2026 EBITDA comes into focus.' A similar sentiment was shown by another analyst only a few days ago. Guggenheim analyst Jason Cassorla upgraded the stock to Buy with a price target of $36. He was optimistic about the long-term outlook of the industry. The company's valuation seems attractive regardless of the current market conditions. However, there is no meaningful short-term catalyst for the business itself, so the direction of the broader market may well determine investor returns in this case. Overall, ACHC ranks 8th on our list of top falling stocks with unusual volume. While we acknowledge the potential of ACHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ACHC but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at . Sign in to access your portfolio
